Field Performance of PIMA Point-of-Care Machine for CD4 Enumeration Under a Mobile HIV Counseling and Testing Program in Remote Fishing Communities of Lake Victoria, Uganda.


Journal

AIDS research and human retroviruses
ISSN: 1931-8405
Titre abrégé: AIDS Res Hum Retroviruses
Pays: United States
ID NLM: 8709376

Informations de publication

Date de publication:
04 2019
Historique:
pubmed: 19 12 2018
medline: 15 4 2020
entrez: 19 12 2018
Statut: ppublish

Résumé

Uganda is among the most HIV/AIDS-afflicted countries, and many HIV-infected persons live in remote areas with poor access to health care. The success of HIV care programs relies in part on patient monitoring using CD4 T cell counts. We conducted an evaluation of the point-of-care PIMA test using BD FACSCount as a gold standard. One hundred fifty-one participants were enrolled, provided venous blood and samples tested at the point of care with the Alere PIMA™ CD4 Analyzer and the BD FACSCount in the UVRI-IAVI main laboratory. Correlation between the methods was assessed, as was the ability of the Pima Analyzer to predict values <200, <350, and ≥500 CD4 cells/mm

Identifiants

pubmed: 30560683
doi: 10.1089/AID.2018.0223
pmc: PMC6461303
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

382-387

Subventions

Organisme : FIC NIH HHS
ID : D43 TW010132
Pays : United States
Organisme : Wellcome Trust
ID : 107743/Z/15/Z
Pays : United Kingdom

Références

Pan Afr Med J. 2015 Jun 09;21:104
pubmed: 26379811
Int J STD AIDS. 2014 Nov;25(13):956-9
pubmed: 24616116
Lancet. 1985 Oct 19;2(8460):849-52
pubmed: 2864575
PLoS One. 2013 Aug 05;8(8):e70770
pubmed: 23940638
Sex Transm Infect. 2011 Oct;87(6):511-5
pubmed: 21835763
PLoS One. 2013 Sep 16;8(9):e75484
pubmed: 24066184
Chin Med J (Engl). 2015 Apr 5;128(7):890-5
pubmed: 25836608
Sex Transm Dis. 2012 Jun;39(6):433-9
pubmed: 22592828
PLoS One. 2013 Jun 25;8(6):e67612
pubmed: 23825674
PLoS Med. 2012;9(3):e1001194
pubmed: 22448150
BMC Infect Dis. 2016 Oct 21;16(1):592
pubmed: 27769181
PLoS One. 2015 Nov 24;10(11):e0143988
pubmed: 26599276
J Int AIDS Soc. 2013 Jul 22;16:18621
pubmed: 23880102
Lancet. 1986 Feb 8;1(8476):307-10
pubmed: 2868172
J Immunol Methods. 2017 Sep;448:44-50
pubmed: 28529048
BMC Med. 2015 Jul 25;13:168
pubmed: 26208867
Clin Infect Dis. 2010 Aug 15;51(4):448-55
pubmed: 20597693
PLoS One. 2014 Mar 10;9(3):e88928
pubmed: 24614083
Sex Transm Infect. 2016 Sep;92(6):447-54
pubmed: 26933046
PLoS One. 2017 Feb 16;12(2):e0171200
pubmed: 28207844

Auteurs

Annemarie Namuniina (A)

1 UVRI-IAVI HIV Vaccine Program Limited, Entebbe, Uganda.

Fredrick Lutwama (F)

1 UVRI-IAVI HIV Vaccine Program Limited, Entebbe, Uganda.
2 Department of Immunology and Molecular Biology, School of Biomedical Sciences, College of Health Sciences, Makerere University, Kampala, Uganda.

Victoria Menya Biribawa (VM)

1 UVRI-IAVI HIV Vaccine Program Limited, Entebbe, Uganda.

David Kizza (D)

1 UVRI-IAVI HIV Vaccine Program Limited, Entebbe, Uganda.

Brian Roy Kabuubi (BR)

1 UVRI-IAVI HIV Vaccine Program Limited, Entebbe, Uganda.

Paul Kato Kitandwe (PK)

1 UVRI-IAVI HIV Vaccine Program Limited, Entebbe, Uganda.

Juliet Mpendo (J)

1 UVRI-IAVI HIV Vaccine Program Limited, Entebbe, Uganda.

Annet Nanvubya (A)

1 UVRI-IAVI HIV Vaccine Program Limited, Entebbe, Uganda.

Julius Ssempiira (J)

1 UVRI-IAVI HIV Vaccine Program Limited, Entebbe, Uganda.

Annet Nalutaaya (A)

1 UVRI-IAVI HIV Vaccine Program Limited, Entebbe, Uganda.

Ali Ssetaala (A)

1 UVRI-IAVI HIV Vaccine Program Limited, Entebbe, Uganda.

Sabrina Welsh (S)

3 International AIDS Vaccine Initiative (IAVI), New York, New York.

Matt A Price (MA)

3 International AIDS Vaccine Initiative (IAVI), New York, New York.
4 Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, California.

Noah Kiwanuka (N)

5 Department of Epidemiology and Biostatistics, School of Public Health, College of Health Sciences, Makerere University, Kampala, Uganda.

Bernard Ssentalo Bagaya (BS)

1 UVRI-IAVI HIV Vaccine Program Limited, Entebbe, Uganda.
2 Department of Immunology and Molecular Biology, School of Biomedical Sciences, College of Health Sciences, Makerere University, Kampala, Uganda.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH